Virtu Financial LLC Biovie Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.4 - $0.56 $17,807 - $24,930	44,518 Added 406.48%	55,470 $22,000
Q1 2024 May 20, 2024	SELL	$0.53 - $1.89 $7,486 - $26,696	-14,125 Reduced 56.33%	10,952 $6,000
Q4 2023 Feb 26, 2024	BUY	$1.22 - $5.24 $30,593 - $131,403	25,077 New	25,077 $32,000
Q2 2022 Aug 09, 2022	BUY	$1.44 - $5.04 $19,208 - $67,228	13,339 New	13,339 $19,000

340K

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $64.3M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.